This is a non-cancerous (benign) growth in the pancreas, which is an organ that makes digestive juices. The pancreas has small clusters of cells called 'islets'. This adenoma affects these islet cells, often the insulin-producing ones. It can cause the body to make too much insulin, which can lead to low blood sugar.
Every report comes from a Lived member, sent anonymously.
Have you had Pancreatectomy for Islet Cell Adenoma?
An islet cell adenoma is a noncancerous (benign) tumor that grows from the islet cells of the pancreas. Islet cells are small clusters scattered through the pancreas that make hormones, including insulin, which lowers blood sugar. Most islet cell adenomas are insulinomas: tumors that keep releasing insulin even when the body does not need it, which pushes blood sugar too low (hypoglycemia). Episodes of low blood sugar tend to happen when someone has gone a long time without food or has skipped or delayed a meal. Typical symptoms include sweating, shakiness, hunger, a fast or pounding heartbeat, headache, blurred or double vision, and confusion or changes in behavior. If blood sugar falls further, a person can pass out or have a seizure. Because eating relieves the symptoms, many people start eating more often and gain weight. Islet cell tumors as a group, also called pancreatic neuroendocrine tumors, can be benign or cancerous, and they are rare. Most insulinomas are benign. Rarer islet cell tumors make other hormones, such as gastrin (which drives stomach acid and ulcers) or glucagon (which raises blood sugar), and these are more often cancerous. All of them are different from the common form of pancreatic cancer, which starts in the cells that make digestive juices and has very different treatment and outlook.
In most people, the reason an islet cell tumor forms is not known. The tumor arises when islet cells change in how they grow and divide, and in an insulinoma those cells also stop responding to the normal signals that switch insulin off when blood sugar is low. Some inherited conditions raise the risk considerably. The best known is multiple endocrine neoplasia type 1 (MEN1), a genetic syndrome that causes tumors in several hormone-making glands; others include von Hippel-Lindau syndrome, neurofibromatosis type 1 and tuberous sclerosis. Most islet cell tumors occur in people without any of these syndromes. When a tumor is found at a younger age, when several tumors appear at once, or when relatives have had similar tumors, doctors may suggest genetic counseling and testing, since the answer can affect treatment and whether family members should be checked. For pancreatic neuroendocrine tumors in general, smoking, type 2 diabetes, long-term inflammation of the pancreas (chronic pancreatitis) and a family history of cancer are linked to higher risk. These are associations, not proof that any one of them caused a particular person's tumor.
Diagnosis starts by proving that the low blood sugar is real and that the body is making too much insulin. Doctors look for a pattern called Whipple's triad: symptoms of low blood sugar, a low blood sugar level measured at the same moment, and relief of the symptoms once blood sugar is raised. For most people a blood sugar below 70 mg/dL counts as low, and the confusion and seizures of severe episodes usually happen at much lower levels. Because episodes are unpredictable, the key test is often a supervised fast, sometimes in the hospital, in which the person stops eating while blood sugar is checked regularly. When blood sugar drops, blood is drawn to measure glucose, insulin, C-peptide (a fragment released along with the body's own insulin) and proinsulin (insulin's precursor), and to screen for diabetes pills that stimulate insulin release. Together these results separate an insulin-making tumor from other causes, such as accidental exposure to diabetes medicines. Only once the blood tests point to too much insulin do doctors look for the tumor. Computed tomography (CT) and magnetic resonance imaging (MRI) scans of the abdomen are common first steps. Insulinomas are often small, so endoscopic ultrasound (an ultrasound probe passed through the mouth into the stomach to view the pancreas up close) or scans that detect hormone-making cells may be needed, and occasionally blood is sampled from the vessels of the pancreas to narrow down the tumor's location. Sometimes the surgeon pinpoints it with ultrasound during the operation. Tissue from a biopsy or from the removed tumor is examined under a microscope to confirm its type and to assign a grade, which describes how quickly the cells appear to be growing.
Surgery to remove the tumor is the main treatment, and for a single benign insulinoma it usually cures the low blood sugar. When the tumor sits near the surface of the pancreas, the surgeon can often remove just the tumor (enucleation) and leave the rest of the organ intact. A deeper tumor, or several tumors, may require removing part of the pancreas: the body and tail (distal pancreatectomy), the middle section (central pancreatectomy), or, for some tumors in the head of the pancreas, a larger operation called a Whipple procedure. Many of these operations can be done through small incisions. Pancreatic surgery carries real trade-offs. The most common complication is a leak of digestive fluid from the cut surface of the pancreas (a pancreatic fistula), which affected roughly one in four people in pooled studies of enucleation, though severe leaks were uncommon. Removing a large portion of the pancreas can cause diabetes or trouble digesting food, which is why surgeons try to preserve as much of the organ as they safely can. Before surgery, or when surgery is not possible or does not find the tumor, medicines can keep blood sugar up. Diazoxide (Proglycem) is a liquid taken by mouth that reduces insulin release; because it makes the body hold on to fluid, it is often paired with a water pill (diuretic). Somatostatin analogs such as octreotide, injected medicines that dampen hormone release, help some people. Eating small, frequent meals also helps prevent episodes. For people who are poor candidates for surgery, the tumor can sometimes be destroyed with heat delivered through an endoscopic ultrasound probe (ablation). In pooled studies this caused fewer complications and shorter hospital stays than surgery, but the tumor came back more often. If an islet cell tumor proves to be cancerous and has spread, most often to the liver, treatment broadens. Options include removing affected liver tissue, blocking the tumor's blood supply (embolization), somatostatin analogs to slow growth, targeted drugs, chemotherapy, and peptide receptor radionuclide therapy (PRRT), an infusion that carries radiation directly to tumor cells.
For most people with a single benign insulinoma, removing it ends the episodes of low blood sugar, and the tumor rarely returns: in pooled studies of enucleation, about 3 in 100 people had a recurrence. Recovery from open or minimally invasive pancreatic surgery often means about a week or more in the hospital. Ablation through an endoscope usually involves a shorter stay. Until the tumor is treated, daily life often revolves around avoiding lows: eating at regular intervals, not skipping meals, and keeping a quick source of sugar, such as juice or glucose tablets, close at hand. Family members and coworkers who know the signs of a low can help early, when eating or drinking something sugary still works. When several tumors are present, as can happen with MEN1, treatment is more involved and tumors can come back, so follow-up continues over the long term. For the cancerous forms of islet cell tumor, outlook depends on the tumor's type, grade and how far it has spread. Across all pancreatic neuroendocrine tumors, about 91 in 100 people whose tumor has not spread beyond the pancreas are alive five years after diagnosis, compared with about 19 in 100 when it has spread to distant organs. These figures describe large groups, not any one person, and follow-up scans and blood tests guide decisions over time.
See a doctor if you have repeated episodes of sweating, shakiness, confusion, blurred vision or a pounding heartbeat after going without food, especially if eating makes them go away. Mention any family history of MEN1 or pancreatic tumors. If you have been treated, contact your care team if episodes of low blood sugar return after surgery or keep happening despite medication. Call 911 if someone with an insulinoma has a seizure, passes out or cannot be woken. If symptoms of a low do not improve after eating or drinking something with sugar, or the person is becoming less alert, get emergency care and do not drive yourself.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Islet Cell Adenoma is like, what's helped you, or ask the community a question.